Mytos website screenshot

Mytos

Mytos is a contract development and manufacturing organization (CDMO) for regenerative medicine and cell therapy. Its iDEM automation platform automates every unit operation of cell culture — coating, seeding, feeding, imaging, passaging and harvesting — in standard 2D T-flask formats, letting clinical-stage biotech companies transfer their manual protocols to automated GMP production at up to 50% lower batch cost, with 10x less labor and cleanroom footprint per batch. Mytos operates a CDMO facility within the Cell and Gene Therapy Catapult site and is backed by Wing Venture Capital. No public developer/API surface was found during enrichment; the profile captures the company's verified security posture (trust center, SOC 2/SOC 3/21 CFR Part 11, domain security, vulnerability disclosure).

Mytos is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Cell Therapy, Regenerative Medicine, and Manufacturing Automation.

🌐 Visit website 📡 Source on GitHub
9.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyCell TherapyRegenerative MedicineManufacturing AutomationCDMOLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 9.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 2.7 / 17
Operational Transparency 1.2 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 3.2 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/mytos: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 3

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Mytos Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Mytos Vulnerability Disclosure

contact published

SECURITY

Mytos Trust Center

SOC 2 Type 2 (2025), SOC 3 (2025), 21 CFR Part 11

SECURITY

Resources

Access & Security 5

Authentication, authorization, and security posture

TrustCenter
TrustCenter
 Compliance
Compliance
 Security
Security
 VulnerabilityDisclosure
VulnerabilityDisclosure
 DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: mytos
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/mytos.png
name: Mytos
description: Mytos is a contract development and manufacturing organization (CDMO) for regenerative medicine and cell therapy.
  Its iDEM automation platform automates every unit operation of cell culture — coating, seeding, feeding, imaging, passaging
  and harvesting — in standard 2D T-flask formats, letting clinical-stage biotech companies transfer their manual protocols
  to automated GMP production at up to 50% lower batch cost, with 10x less labor and cleanroom footprint per batch. Mytos
  operates a CDMO facility within the Cell and Gene Therapy Catapult site and is backed by Wing Venture Capital. No public
  developer/API surface was found during enrichment; the profile captures the company's verified security posture (trust center,
  SOC 2/SOC 3/21 CFR Part 11, domain security, vulnerability disclosure).
url: https://raw.githubusercontent.com/api-evangelist/mytos/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- wing-venture-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Cell Therapy
- Regenerative Medicine
- Manufacturing Automation
- CDMO
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.mytos.bio/
- type: TrustCenter
  url: security/mytos-trust-center.yml
- type: Compliance
  url: https://trust.mytos.bio/
- type: Security
  url: https://trust.mytos.bio/
- type: VulnerabilityDisclosure
  url: security/mytos-vulnerability-disclosure.yml
- type: DomainSecurity
  url: security/mytos-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: enriched
  artifacts_added: 3
  pass: local-v1